You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 214869


✉ Email this page to a colleague

« Back to Dashboard


NDA 214869 describes DHIVY, which is a drug marketed by Avion Pharms and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the DHIVY profile page.

The generic ingredient in DHIVY is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.
Summary for 214869
Tradename:DHIVY
Applicant:Avion Pharms
Ingredient:carbidopa; levodopa
Patents:3
Pharmacology for NDA: 214869
Suppliers and Packaging for NDA: 214869
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DHIVY carbidopa; levodopa TABLET;ORAL 214869 NDA Avion Pharmaceuticals, LLC 75854-701 75854-701-01 100 TABLET in 1 BOTTLE (75854-701-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG;100MG
Approval Date:Nov 12, 2021TE:RLD:Yes
Patent:⤷  Sign UpPatent Expiration:Mar 28, 2039Product Flag?YSubstance Flag?Delist Request?
Patented Use:METHOD OF TREATING PARKINSON'S DISEASE BY ORALLY ADMINISTERING A FUNCTIONALLY MULTISCORED, BILAYERED TABLET HAVING CARBIDOPA—25 MG/LEVODOPA—100 MG
Patent:⤷  Sign UpPatent Expiration:Mar 28, 2039Product Flag?YSubstance Flag?Delist Request?
Patented Use:METHOD OF TREATING PARKINSON'S DISEASE BY ORALLY ADMINISTERING SEGMENTS OF A FUNCTIONALLY MULTISCORED, BILAYERED TABLET HAVING CARBIDOPA—25 MG/LEVODOPA—100 MG, EACH SEGMENT HAVING CARBIDOPA—6.25 MG/LEVODOPA—25 MG
Patent:⤷  Sign UpPatent Expiration:Mar 28, 2039Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF PARKINSON'S DISEASE

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.